Adgero Biopharmaceuticals Holdings, Inc.
Related Filers (1)
Other (3)
D
Friday, 9/9/2016
Exempt (Private) Offering
D
Tuesday, 4/19/2016
Exempt (Private) Offering
D
Tuesday, 11/24/2015
Exempt (Private) Offering
Prospectus (8)
425
Tuesday, 8/18/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 8/17/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 7/28/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
RW
Thursday, 9/27/2018
Registration Withdrawal Request
S-1/A
Tuesday, 10/17/2017
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 4/11/2017
General form of registration statement for all companies including face-amount certificate companies
S-1
Tuesday, 2/14/2017
General form of registration statement for all companies including face-amount certificate companies
DRS
Thursday, 11/3/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy